Management of INR 6 with Warfarin on Hold
For a patient with INR 6 (rising from 4 yesterday) who is currently off warfarin and not actively bleeding, you should administer oral vitamin K 1-2.5 mg in addition to continuing to hold warfarin. 1
Clinical Reasoning
Your patient's INR has risen from 4 to 6 despite holding warfarin, which indicates continued over-anticoagulation and suggests the INR may continue to rise. This trajectory matters more than the absolute number.
Why Vitamin K is Recommended
The American College of Chest Physicians guidelines specifically address this scenario: for INR between 5 and 9 without bleeding, if the patient has ANY risk factors that predispose to bleeding, vitamin K (1-2.5 mg) orally should be given in addition to holding warfarin. 1
Risk factors for bleeding include:
- Age ≥65 years
- History of stroke or GI bleeding
- Renal insufficiency or anemia
- Concomitant antiplatelet agents or NSAIDs
- Comorbid conditions 1
Evidence Supporting This Approach
Oral vitamin K 1-2.5 mg more rapidly lowers the INR to <5 within 24 hours compared to simply withholding warfarin alone. 1 In a prospective study of 62 patients with INR 4-10, after administering 1 mg oral vitamin K:
- 95% had lower INR at 24 hours
- 85% achieved INR <4
- 35% reached INR <1.9
- Importantly, none developed warfarin resistance when therapy was resumed 1
Route of Administration Matters
Use oral vitamin K (the injectable formulation given orally is preferred), NOT subcutaneous. 1, 2 Here's why:
- Oral administration is predictably effective and safe
- Subcutaneous vitamin K has unpredictable and sometimes delayed response 1
- IV vitamin K carries risk of anaphylaxis and should be reserved for emergencies 1
If Patient Has NO Bleeding Risk Factors
If your patient truly has no risk factors for bleeding, the guidelines allow for simply holding warfarin for 1-2 doses and monitoring closely. 1, 3 However, the 2012 ACCP guidelines note that while vitamin K may reverse supratherapeutic INRs more rapidly, there was no evidence of benefit for patient-important outcomes in this lower-risk group. 3
The critical caveat: Even without vitamin K, the absolute daily risk of bleeding remains low when INR is 5-10. 1 However, given your patient's INR is rising despite holding warfarin, this suggests ongoing risk.
Common Pitfalls to Avoid
- Don't use high-dose vitamin K (10 mg) - this may lower INR excessively and cause warfarin resistance for up to a week 1
- Don't give subcutaneous vitamin K - response is unpredictable 1
- Don't use IV vitamin K unless there's major bleeding - anaphylaxis risk 1
- Don't forget to recheck INR in 24 hours to assess response 1
Monitoring Plan
- Recheck INR in 24 hours
- If INR remains >5 after 24 hours, consider additional 1-2 mg vitamin K 1
- Once INR approaches therapeutic range, restart warfarin at a lower dose 1
- Monitor closely for signs of bleeding (even though risk is low)
When to Escalate
If the patient develops any bleeding or has INR >9, increase vitamin K dose to 3-5 mg orally. 1 For major bleeding or life-threatening situations, immediate reversal with prothrombin complex concentrate plus IV vitamin K 10 mg is required. 1, 4